In 2023, the R&D budget for Health and Medical Sciences in France accounted for a certain percentage of the total government budget allocations for research and development (Total GBARD). For the years 2024 through 2028, the forecast indicates a gradual increase in this allocation, rising from 18.57% in 2024 to 18.81% by 2028. The annual growth shows minimal variation, demonstrating a steady year-on-year increase. Evaluating over a five-year span, the compound annual growth rate (CAGR) suggests consistent, albeit modest, growth in the R&D budget allocation.
Future trends to monitor include potential shifts in government priorities that may increase or decrease the allocations, as well as economic changes that could impact funding availability. Additionally, the influence of technological advancements and health crises, such as pandemics, may necessitate increased investment in this sector.
